Administration of neoadjuvant chemotherapy prior to liver resection, with objective tumour response classified as partial response (PR) or stable disease (SD) according to RECIST criteria.
Availability of a hepatobiliary contrast-enhanced MRI performed within 2 months before surgery.
Provision of informed consent for prospectively enrolled participants, or eligibility under Article 110-bis of the Italian Privacy Code for retrospectively enrolled participants.
You may not be if
Recurrent metastatic disease.
Liver resection performed with non-curative intent.
Current or previous hepatitis B virus (HBV) or hepatitis C virus (HCV) infection.
Concomitant malignancies or history of another malignancy treated within the previous 5 years.
Clareo Health | Radiogenomic Profiling of Dendritic Cells and Macrophages to Predict Recurrence in Colorectal Liver Metastasis
